BD Solutions for Efficient Management of HAIs
|
Products & Services
| 1 - Preventing the spread of drug-resistant bacteria : Rapid molecular assays » | |
| 2 - Reliable detection, identification and screening with BD BBL™ CHROMagar™ Products.» | |
| 3 - Accurate Diagnosis for Appropriate Antibiotic Usage » | |
| 4 - Efficient communication tools for laboratory and hospital » | |
| BD is proud to support Infection Preventionists worldwide as a 2009 APIC Strategic Partner Learn more » |
| BD is a member of the Strategic Partnership program of the International Federation of Infection Control Learn more » |
Learn more about...
| Literature References » |
|
| BD Adds Surveillance Capability to Infectious Disease Portfolio » » |
|
HAI Archive» |

Healthcare-associated infections (HAIs) are a major cause of morbidity and mortality around the world. An estimated 6 million healthcare-associated infections occur each year across the U.S., Europe and Japan alone. Beyond the human toll, HAIs poses an enormous financial burden to healthcare systems worldwide. BD is committed to applying its expertise, resources and technologies toward the prevention of healthcare-associated infections worldwide. Helping to prevent HAIs perfectly aligns with BD's core purpose of "helping all people live healthy lives".